Table 4 A shows the univariate and adjusted results at 2 years follow-up of the association between CCL18 and cardiac mortality, and between CCL18 and the combined endpoints consisting of cardiac mortality or MI or stroke, for the AMI and non-AMI group of patients, respectively. Here, CCL18 is linked to myocardial infarction.